Scope of the Study
The consumer genome can predict the risk of developing diseases brought on by a single gene defect, but the defects only account for five percent of common diseases. The technology of the genotyped consumer will be point-of-use tools and tests based on genome databases. Genome is becoming more reliable, but many scientists still question if it reduces the risk of death from certain diseases such as prostate cancer. Embryo screening tools will be generally available. Consumer genomics is now being used in a wide variety of fields, such as metagenomics, pharmacogenomics, and mitochondrial genomics. Genomics is applied to understand and find cures for diseases.
The market study is being classified, by Application (Genetic Relatedness, Diagnostics, Wellness and Nutrition, Ancestry, Reproductive Health and Others) and major geographies with country level break-up.
23andMe, Inc. (United States), Color Genomics (United States), F. Hoffmann-La Roche (Switzerland), Gene by Gene (United States), Thermo Fisher Scientific (United States), Laboratory Corporation of America (United States), Mapmygenome India (India), Quest Diagnostics, Inc. (United States), Helix OpCo LLC (United States), PacBio (United States), ALL-TAG Corporation (United States), Ancestry (United States) and Centrillion Technology Holdings Ltd. (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Toolbox Genomics (United States), Pathway Genomics (United States), Gene By Gene, Ltd. (United States) and Diagnomics, Inc. (United States).
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Consumer Genomics market throughout the predicted period.
AdvanceMarketAnalytics has segmented the market of Global Consumer Genomics market by Type, Application and Region.
On the basis of geography, the market of Consumer Genomics has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Easy Obtainability of Maternal and Paternal Tests with Minimal Requirement of Genetic Counseling
- Rising Awareness about Non-Invasive Prenatal Testing
- Advancements in the Field of Diagnostics and Use of Genomic Data
- Increasing Clinical and Ethical Problems Related To the Use of DTC Products
- Lack of Adoption of Home-Based Genetic Tests Due To Misleading Results
- Rising Demand for Personalized Genomics
Key Target AudienceManufacturers of Consumer Genomics Products, Suppliers of Consumer Genomics Products, Consumer Genomics Service Providers, Healthcare Industry and Regulatory Bodies
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase